Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
| Quarter | Letter Date | Fund Name | QTD | YTD | Tickers | Themes | Quick Take |
|---|---|---|---|---|---|---|---|
Buyside Digest is not affiliated with, and does not endorse, Harding Loevner International Small Companies Equity. This analysis is provided for institutional research purposes only and is not investment advice.
"The portfolio underperformed in Q3 2025 as the market favored high-beta momentum stocks and commodity miners. Harding Loevner remains anchored in its long-term quality-compounder strategy, adding to resilient IT services and health care equipment holdings on weakness."
During Q3 2025, the Harding Loevner International Small Companies Equity composite fell 0.92% (Gross) / 1.13% (Net), underperforming the benchmark index's 6.80% gain. This performance gap was primarily driven by a market rally characterized by high-beta, momentum-led equities and a surge in the Materials sector (particularly gold miners), which the portfolio intentionally underweights due to structural concerns. The manager remains committed to quality-growth-value discipline. In Health Care, the fund avoids drugmakers and favors equipment suppliers, highlighting high recurring revenues in positions like Medistim, Sysmex, and Carl Zeiss Meditec. In IT services, the fund addressed AI disruption fears, clarifying that cyclical slowdowns represent the primary hurdle for most holdings (e.g., Bechtle, Reply), while those exposed (e.g., Globant) are actively adapting. Portfolio modifications during the quarter featured the establishment of positions in Besi, Sysmex, Haier Biomedical, and Hexpol, alongside the full sale of CyberArk, Robinsons Retail, Sarana Menara Nusantara, and Stanley Electric.
Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.
Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.
Market Conviction
High-conviction positioning: The portfolio underperformed in Q3 2025 as the market favored high-beta momentum stocks and commodity miners. Harding Loevner remains anchored in its long-term quality-compounder s...
Growth Outlook
Market outlook remains above average conviction: The portfolio underperformed in Q3 2025 as the market favored high-beta momentum stocks and commodity miners. Harding Loevner remains anchored in its long-term quality-compounder s...
Risk Appetite
Risk appetite posture is moderate conviction: The portfolio underperformed in Q3 2025 as the market favored high-beta momentum stocks and commodity miners. Harding Loevner remains anchored in its long-term quality-compounder s...
Capital Deployment
Manager actively deployed capital into high-conviction opportunities. The portfolio underperformed in Q3 2025 as the market favored high-beta momentum stocks and commodity miners. Harding Loevner remains anchored in its long-term quality-compounder s...
Forward Guidance
Forward guidance signal: The portfolio underperformed in Q3 2025 as the market favored high-beta momentum stocks and commodity miners. Harding Loevner remains anchored in its long-term quality-compounder s...
Language Signal
Tone analysis indicates above average conviction language: The portfolio underperformed in Q3 2025 as the market favored high-beta momentum stocks and commodity miners. Harding Loevner remains anchored in its long-term quality-compounder s...
Perceived Risk
Perceived risk level is evaluated as moderate conviction. The portfolio underperformed in Q3 2025 as the market favored high-beta momentum stocks and commodity miners. Harding Loevner remains anchored in its long-term quality-compounder s...
Opportunity Density
Opportunity density index indicates above average conviction actionable entry points. The portfolio underperformed in Q3 2025 as the market favored high-beta momentum stocks and commodity miners. Harding Loevner remains anchored in its long-term quality-compounder s...
Time Horizon
Investment time horizon reflects a high conviction orientation. The portfolio underperformed in Q3 2025 as the market favored high-beta momentum stocks and commodity miners. Harding Loevner remains anchored in its long-term quality-compounder s...
